I agree that this site is using cookies. You can find further informations here.
X
Sevigny, Jeffrey
42  results:
Search for persons X
?
1

Progranulin AAV gene therapy for frontotemporal dementia: t..:

Sevigny, Jeffrey ; Uspenskaya, Olga ; Heckman, Laura Dean...
Nature Medicine.  30 (2024)  5 - p. 1406-1415 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Phase 1/2 study update of an AAV9-based gene therapy for Ga..:

Neuhaus, Sarah ; Lewis, Travis B. ; Tamburri, Paul A....
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 107238 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Design and outcome measures for a phase 1/2 dose-finding st..:

Neuhaus, Sarah ; Tamburri, Paul A. ; Weaver, Michael A....
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 107239 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Gene Therapy for Parkinson's Disease Associated with GBA1 M..:

Abeliovich, Asa ; Hefti, Franz ; Sevigny, Jeffrey...
Journal of Parkinson's Disease.  11 (2021)  s2 - p. S183-S188 , 2021
Link: https://doi.org/10.3233/..
 
?
5

Design of Phase 1/2a Study of AAV9-Based Gene Therapy for P..:

Uspenskaya, Olga ; Mahoney, Erin ; Verselis, Lynne...
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
6

Design of a Phase 1/2 study of an AAV9‐based gene therapy f..:

Uspenskaya‐Cadoz, Olga ; Benoit, Jamie ; Mahoney, Erin...
Alzheimer's & Dementia.  16 (2020)  S9 - p. , 2020
Link: https://doi.org/10.1002/..
 
?
7

Combination therapy for Alzheimer's disease: Are we ready?:

Salloway, Stephen ; Sevigny, Jeffrey ; Bain, Lisa J...
Alzheimer's & Dementia.  14 (2018)  9 - p. 1232-1233 , 2018
Link: https://doi.org/10.1016/..
 
?
8

S43. A PROOF-OF-MECHANISM STUDY OF THE PDE10 INHIBITOR RG72..:

Umbricht, Daniel ; Dukart, Jürgen ; Abt, Markus...
Schizophrenia Bulletin.  44 (2018)  suppl_1 - p. S340-S341 , 2018
Link: https://doi.org/10.1093/..
 
?
9

Current state of Alzheimer's fluid biomarkers:

Molinuevo, José Luis ; Ayton, Scott ; Batrla, Richard...
Acta Neuropathologica.  136 (2018)  6 - p. 821-853 , 2018
Link: https://doi.org/10.1007/..
 
?
10

Motor, cognitive, and functional declines contribute to a s..:

Schobel, Scott A. ; Palermo, Giuseppe ; Auinger, Peggy...
Neurology.  89 (2017)  24 - p. 2495-2502 , 2017
Link: https://doi.org/10.1212/..
 
?
11

Randomized, Double-Blind, Placebo-Controlled Studies to Eva..:

Viglietta, Vissia ; O'Gorman, John ; Williams, Leslie...
Neurology.  86 (2016)  16_supplement - p. , 2016
Link: https://doi.org/10.1212/..
 
?
12

P1–359: A single ascending‐dose study of BIIB037 in people ..:

Sevigny, Jeffrey ; Williams, Leslie ; Ferrero, Jim...
Alzheimer's & Dementia.  9 (2013)  4S_Part_7 - p. , 2013
Link: https://doi.org/10.1016/..
 
?
13

P3‐275: Optimization of the treatment regimen with active A..:

Graf, Ana ; Andreasen, Niels ; Riviere, M.E....
Alzheimer's & Dementia.  6 (2010)  4S_Part_17 - p. , 2010
Link: https://doi.org/10.1016/..
 
?
14

Early risk assessment for Alzheimer's disease:

Carrillo, Maria C. ; Blackwell, Andrew ; Hampel, Harald...
Alzheimer's & Dementia.  5 (2009)  2 - p. 182-196 , 2009
Link: https://doi.org/10.1016/..
 
?
15

Review: Item Analysis of ADAS-Cog: Effect of Baseline Cogni..:

Sevigny, Jeffrey J. ; Yahong Peng ; Lian Liu.
American Journal of Alzheimer's Disease & Other Dementiasr.  25 (2009)  2 - p. 119-124 , 2009
Link: https://doi.org/10.1177/..
 
1-15